NDC 66298-7131-03 - Linezolid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66298-7131
- Requested NDC
- 66298-7131-03
- Package NDCs from labels
- 66298-7131-3, 66298-7131-03
- Manufacturer
- Hp Halden Pharma AS
- Effective date
- 2024-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Linezolid - Hp Halden Pharma AS | Hp Halden Pharma AS | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66298-7131-3 | Linezolid | 300 mL in 1 BAG | INJECTION, SOLUTION | 300 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66298-7131 | LINEZOLID INJECTION, SOLUTION [HP HALDEN PHARMA AS] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240719_217f3ee2-2534-4c32-8e9d-09b6d65df4af.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Linezolid | LINEZOLID | A-S Medication Solutions | 3d630d3d-510d-43a4-8703-8b6234831564 | 2026-09-03 | Warnings, Adverse reactions | ISQ9I6J12J |
| Kroger Anti Nausea Cherry Flavor | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | KROGER COMPANY | fb7326db-3512-45ee-9a9b-48f3ebd8d0c5 | 2026-09-02 | Warnings | IY9XDZ35W2 |
| Linezolid | LINEZOLID | Rising Pharma Holdings, Inc. | bf4fa35d-93c9-41c3-a2ae-0298014b8a9f | 2026-08-24 | Warnings, Adverse reactions | ISQ9I6J12J |
| CVS Anti Nausea Cherry Flavor | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | CVS PHARMACY | f6f7568b-3887-434d-9403-a3ecdc591bbc | 2026-08-17 | Warnings | IY9XDZ35W2 |
| Adaptopath | ADENOSINUM CYCLOPHOSPHORICUM, ALPHA-LIPOICUM ACIDUM, ARGENTUM METALLICUM, AVENA SATIVA, CAPSICUM ANNUUM, CITRICUM ACIDUM, COENZYME A, CUPRUM METALLICUM, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYPOTHALAMUS (BOVINE), IODIUM, LEDUM PALUSTRE, MANGANUM ACETICUM, NADIDUM, NATRUM CARBONICUM, OLEUM MORRHUAE, PHOSPHORICUM ACIDUM, PICRICUM ACIDUM, RIBOFLAVINUM, SELENIUM METALLICUM SEPIA, SILICEA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), VANADIUM METALLICUM | Energetix Corporation | 41234598-0cb5-41c2-bfbe-1c15ee9bf502 | 2026-08-11 | Warnings | XF417D3PSL |
| Aller-Chord A | ALFALFA, ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, BRYONIA (ALBA), CITRICUM ACIDUM, COUMARINUM, EUPHRASIA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, JUNIPERUS COMMUNIS, MUCOSA NASALIS SUIS, NATRUM SULPHURICUM, PHOSPHORUS, POTHOS FOETIDUS, PULSATILLA (VULGARIS), SOLIDAGO VIRGAUREA, SULPHUR, TANACETUM VULGARE, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE | Energetix Corporation | 09e89c92-112d-4320-9df5-b9f938bb9095 | 2026-08-11 | Warnings | XF417D3PSL |
| Hepatic-Tone | CARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CITRICUM ACIDUM, CYSTEINUM, HEPAR SUIS, LEPTANDRA VIRGINICA, MAGNESIA MURIATICA, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS, QUASSIA (AMARA), TARAXACUM OFFICINALE | Energetix Corporation | d5f61f13-7e9f-4e46-8ad8-0336f36288df | 2026-08-11 | Warnings | XF417D3PSL |
| Isopathic Phenolic Rings | HOMEOPATHIC LIQUID | Energetix Corporation | 98a7ca26-ccb7-43c7-bd65-892fcbacc882 | 2026-08-11 | Warnings | XF417D3PSL |
| Metabopath | ADENOSINUM CYCLOPHOSPHORICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, BERBERIS VULGARIS, CITRICUM ACIDUM, COENZYME A, DNA, FUMARICUM ACIDUM, GLYCYRRHIZA GLABRA, HEPAR SULPHURIS CALCAREUM, LAPPA MAJOR, MAGNESIA PHOSPHORICA, MANGANUM ACETICUM, NADIDUM, NATRUM MURIATICUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PULSATILLA, PYRIDOXINUM HYDROCHLORICUM, RHAMNUS PURSHIANA, RIBOFLAVINUM, RNA, SILICEA, SUCCINICUM ACIDUM, SULPHUR, THIAMINUM HYDROCHLORICUM, | Energetix Corporation | 58bfe670-d308-45a2-8046-7897b6221452 | 2026-08-11 | Warnings | XF417D3PSL |
| Linezolid | LINEZOLID | Sun Pharmaceutical Industries, Inc. | 870c9600-04d5-4b44-a5b5-02252a310f22 | 2026-07-31 | Warnings, Adverse reactions | 1662285 ISQ9I6J12J |
| Xenleta | LEFAMULIN ACETATE | Meitheal Pharmaceuticals Inc. | eb972ea8-7502-422e-84bb-66cb8e93ca06 | 2026-07-22 | Warnings, Adverse reactions | XF417D3PSL |
| Best Choice Anti Nausea Cherry Flavor | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | BEST CHOICE (VALU MERCHANDISERS COMPANY) | bc8b5208-2dbf-4636-8dd8-68c1ab975f57 | 2026-07-17 | Warnings | IY9XDZ35W2 |
| Linezolid | LINEZOLID | Macleods Pharmaceuticals Limited | 90dd8c13-c428-4472-91e5-5b1fcdc4fce3 | 2026-07-15 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Hikma Pharmaceuticals USA Inc. | 16007ca5-7956-4414-af38-406a6623400e | 2026-07-15 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Eugia US LLC | b721756c-3b5e-456d-a2f6-0d8a56cc7f35 | 2026-07-13 | Warnings, Adverse reactions | 1662285 ISQ9I6J12J |
| Good Neighbor Anti Nausea Cherry Flavor | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | AMERISOURCE BERGEN | 82488773-3fef-41a0-afa7-e74ea19cd87d | 2026-07-13 | Warnings | IY9XDZ35W2 |
| Zyvox | LINEZOLID | Pharmacia & Upjohn Company LLC | 3e5e9975-6f36-42e4-ab46-0e75dda83592 | 2026-07-09 | Warnings, Adverse reactions | 1662285 ISQ9I6J12J |
| Linezolid | LINEZOLID | Mylan Pharmaceuticals Inc. | 83a84897-ccca-42a1-ab1a-bbf1d43a982b | 2026-07-09 | Warnings, Adverse reactions | ISQ9I6J12J |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 4c0dec79-1648-1cfd-e063-6394a90a88cc | 2026-07-03 | IY9XDZ35W2 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a82ea8-69bf-f061-e063-6394a90af3da | 2026-07-03 | IY9XDZ35W2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.